David Mountcastle - Mar 21, 2022 Form 3/A - Amendment Insider Report for Privia Health Group, Inc. (PRVA)

Role
EVP & Chief Financial Officer
Signature
/s/Thomas Bartrum, , as attorney-in-fact
Stock symbol
PRVA
Transactions as of
Mar 21, 2022
Transactions value $
$0
Form type
3/A - Amendment
Date filed
12/20/2022, 03:08 PM
Date Of Original Report
Apr 1, 2022
Previous filing
Jan 7, 2022
Next filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PRVA Common Stock, $0.01 par value per share 32.3K Mar 21, 2022 Direct F1
holding PRVA Common Stock, $0.01 par value per share 8.7K Mar 21, 2022 By spouse F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PRVA Stock Option (Right to Purchase) Mar 21, 2022 Common Stock 128K $2.00 Direct F3
holding PRVA Stock Option (Right to Purchase) Mar 21, 2022 Common Stock 97K $2.00 Direct F4
holding PRVA Stock Option (Right to Purchase) Mar 21, 2022 Common Stock 37.2K $2.00 Direct F5
holding PRVA Stock Option (Right to Purchase) Mar 21, 2022 Common Stock 41.7K $2.00 Direct F6
holding PRVA Stock Option (Right to Purchase) Mar 21, 2022 Common Stock 103K $23.00 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 22,826 restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the second, third and fourth anniversaries of the grant date. The restricted stock units were granted on April 28, 2021.
F2 These shares were omitted from the reporting person's original Form 3, and also were omitted from 10 Forms 4 filed by the reporting person after his original Form 3 was filed.
F3 Reflects stock options to purchase shares of common stock, $0.01 par value per share, of the Issuer under the Issuer's Second Amended and Restated PH Group Parent Corp. Stock Option Plan (the "Plan"). 76,556 of the stock options are fully vested and exercisable.The remaining unvested stock options are scheduled to vest and become exercisable 50% on the 12 month anniversary of the Issuer's initial public offering and 50% on the 18 month anniversary of the Issuer's initial public offering.
F4 Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 62,509 stock options are fully vested and exercisable. The remaining unvested stock options are scheduled to vest and become exercisable 50% on the 12 month anniversary of the Issuer's initial public offering and 50% on the 18 month anniversary of the Issuer's initial public offering.
F5 Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 21,804 of the stock options are fully vested and exercisable. 2,493 of the stock options will vest December 4, 2022.The remaining unvested stock options are scheduled to vest and become exercisable 50% on the 12 month anniversary of the Issuer's initial public offering and 50% on the 18 month anniversary of the Issuer's initial public offering.
F6 Reflects stock options to purchase shares of common stock of the Issuer under the Plan. 20,000 of the stock options are fully vested and exercisable. 4,166 of the stock options will vest on September 8, 2022 and 4,167 of the stock options will vest on September 8, 2023.The remaining unvested stock options are scheduled to vest and become exercisable 50% on the 12 month anniversary of the Issuer's initial public offering and 50% on the 18 month anniversary of the Issuer's initial public offering.
F7 Reflects stock options to purchase shares of common stock of the Issuer under the Issuer's 2021 Omnibus Incentive Plan that will vest in equal installments on the second, third and fourth anniversaries of the grant date. The stock options were granted on April 28, 2021.